78º
    • News
    • Watch Live
    • Local News
    • Defenders
    • Crime
    • Courts
    • Vote 2022
    • Texas
    • Border
    • SAQ
    • Education
    • Consumer
    • Behind the Kitchen Door
    • Data
    • Health
    • National
    • World
    • Solutionaries
    • Trust Index
    • News App
    • Weather
    • Traffic
    • Pollen
    • Alerts
    • Doppler Radar
    • Traffic Cams
    • Rooftop Weather
    • Weather History
    • Climate
    • Kaiti's Science Lab
    • Thermometer Thursday
    • Weather 101
    • Hurricanes
    • KSAT Connect
    • Weather App
    • Daily Forecast
    • Sports
    • Big Game Coverage
    • BGC Streams
    • KSAT Pigskin Classic
    • Spurs
    • NFL
    • Instant Replay
    • College
    • Scholar Athletes
    • UTSA
    • Spurs Newsletter
    • Spurs Stats
    • BGC Newsletter
    • BGC App
    • Coronavirus
    • Find A Vaccine
    • Find A Test
    • Track Local Cases
    • Vaccine News
    • Map: Infection Rates
    • World Case Count
    • Coronavirus Newsletter
    • KSAT Plus
    • Watch Live
    • Newscasts
    • KSAT News Now
    • KSAT Explains
    • Breakdown
    • Texas Eats
    • 9 @ 9
    • Leading SA
    • Necessary Evil
    • South Texas Crime Stories
    • Downfall
    • In The Shadows
    • Mental Wellness
    • QVC
    • TV Listings
    • Meet the Team
    • Streaming App
    • SA Live
    • As Seen On SA Live
    • Happy Space
    • Texas Eats
    • Prize Wheel
    • Big Adventure
    • Meet The Cast
    • Things to Do
    • Entertainment
    • Things To Do
    • KSAT Kids
    • Outdoors
    • Trending
    • Travel
    • Something Good
    • Fiesta
    • Money
    • Food
    • Rodeo
    • Selena
    • Weird News
    • Birthdays
    • Events Calendar
    • Features
    • KSAT Insider
    • KSAT Deals
    • KSAT Community
    • Podcasts
    • Black History
    • San Antonio Business Journal
    • Live from the Southside
    • Military City USA
    • Great Grads
    • Jobs
    • Contests & Rules
    • MeTV
    • KSAT Experts
    • Educator of the Month
    • Newsletters
  • News
  • Weather
  • Sports
  • Coronavirus
  • KSAT Plus
  • SA Live
  • Entertainment
  • Features
  • Newsletters
KSAT.com
  • News
  • Weather
  • Sports
  • Coronavirus
  • KSAT Plus
  • SA Live
  • Entertainment
  • Features
  • Newsletters
Ad

JOHNSON & JOHNSON


16 hours ago

A major slide in this tech stock allows us to be buyers again

We're making a few trades in the portfolio Friday, selling a less favored name to buy higher quality stocks.

cnbc.com
2 days ago

We're selling half of a retail holding to get into an undervalued health care stock

The high grading of our portfolio continued Wednesday morning, with the moves made on American Eagle Outfitters and Johnson & Johnson.

cnbc.com
3 days ago

We're adding an appliance maker to our Bullpen as we look for new stocks to buy

After calling up a handful of names, we want to refresh a company already in our Bullpen, in addition to putting another one on it.

cnbc.com

Idaho announces $119 million opioid crisis settlement

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

npr.org

J&J names Thibaut Mongon, current consumer health leader, as CEO of new spin-off company

J&J announced in November that it would sheer off the consumer health business from its faster-growing medical devices and pharmaceutical portfolios.

cnbc.com

Baltimore vaccine maker hid potential problem, House report says

Cross-contamination of coronavirus vaccines being made for Johnson & Johnson and AstraZeneca was discovered in March 2021. The company had more than $1.3 billion worth of contracts from the federal government and from Johnson & Johnson and AstraZeneca to make the vaccines. The hold tags indicated a potential quality problem with the vaccine in the containers, the House panel found. After discovery of cross-contamination, the Biden administration suspended the plant’s production of the Johnson & Johnson vaccine in April and permanently halted production of the AstraZeneca vaccine at the plant. But even after the restart in August, problems continued, according to the House report.

washingtonpost.com

Judge Lets Tulsa Race Massacre Reparations Lawsuit Proceed

The suit seeks punitive damages, calls for a hospital, mental health and education programs, as well as a Tulsa Massacre Victims Compensation Fund.

newsy.com

Stocks making the biggest moves midday: Twitter, Johnson & Johnson, WeWork and more

These are the stocks posting the largest moves in midday trading.

cnbc.com

J&J suspends COVID-19 vaccine sales forecast

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

Ad

J&J lowers 2022 revenue and earnings expectations, stops giving Covid vaccine sales guidance

Johnson & Johnson on Tuesday lowered its full-year sales and earnings outlook, and stopped providing Covid-19 vaccine sales guidance due to a global supply surplus and demand uncertainty. J&J is now forecasting 2022 sales of $94.8 billion to $95.8 billion, about one billion dollars lower than the guidance provided in January. J&J reported first-quarter sales of $23.4 billion, slightly missing Wall Street expectations but growing 5% over the same quarter last year. The company's medical devices business grew by 5.9% to $6.97 billion in sales compared to the first quarter of 2021. "Looking ahead, I remain confident in the future of Johnson & Johnson as we continue advancing our portfolio and innovative pipeline."

cnbc.com

Stock futures nudge higher ahead of busy earnings day

Stock futures moved higher early Tuesday morning after stocks slipped during regular trading hours on Monday.

cnbc.com

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths.

Johnson & Johnson Ordered To Pay $302M In Pelvic Mesh Case

An appeals court judge found that the company made misleading and potentially harmful statements in advertisements and instructional brochures.

newsy.com

Appeals court: J&J must pay $302M in pelvic mesh case

A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay $302 million in penalties to the state for deceptively marketing pelvic mesh implants for women.

EXPLAINER: Where do US opioid trials, settlements stand?

A trial on whether pharmacy chain Walgreens bears responsibility for the opioid crisis started Monday in Florida on the heels of opening statements last week in another opioid trial in West Virginia.

WVa trial expert: Drug makers downplayed risks in marketing

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers.

Rich companies are using a quiet tactic to block lawsuits: bankruptcy

Companies that aren't bankrupt are using controversial maneuvers in U.S. bankruptcy court to block tens of thousands of suits. A woman suing Johnson & Johnson died while her case was in legal limbo.

npr.org

Next decade will transform health care more than past century: Johnson & Johnson CEO

Johnson & Johnson's new CEO Joaquin Duato says in his first interview that AI in medicine will lead to innovations including real-time surgery decisions.

cnbc.com
Ad

J&J and other opioid players to pay $26 billion to states over roles in addiction crisis

"It's not enough, but it's a good start," one lawyer said of settlement to fund local treatment and education efforts.

cbsnews.com

Johnson & Johnson wins a key court battle in baby powder case

A federal judge has allowed a Johnson & Johnson spinoff to proceed with a controversial bankruptcy, despite complaints from thousands who say they were harmed by the company's baby powder.

npr.org

4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis

The companies, including Johnson & Johnson and McKesson, will admit no wrongdoing. Billions of dollars in payouts will fund drug treatment and harm reduction programs.

npr.org

J&J, distributors finalize $26B landmark opioid settlement

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis.

Sure and Brut deodorant sprays recalled nationwide after benzene detected

Analysis finds "unexpected levels" of human carcinogen coming from propellant that sprays product out of the can.

cbsnews.com

Moderna, Pfizer stocks fall as omicron Covid wave subsides in U.S.

Moderna dropped more than 12%, the biggest decline in the S&P 500 as of Monday afternoon.

cnbc.com

Johnson & Johnson halts production of single-dose COVID-19 vaccine, report says

Drugmaker reportedly closed the Dutch plant that was making the vaccine in order to focus on a different drug.

cbsnews.com

Johnson & Johnson halts production of single-dose COVID-19 vaccine, report says

Drugmaker reportedly closed the Dutch plant that was making the vaccine in order to focus on a different drug.

cbsnews.com

Johnson & Johnson plant pauses Covid vaccine production, report says

The only Johnson & Johnson facility making usable batches of the company's Covid vaccine has temporarily halted its production, The New York Times reported.

cnbc.com
Ad

Tribes: Settlement in opioids case will foster healing

Money that will flow to Native American tribes as part of an opioid drug settlement with a major manufacturer and three distributors won't come quickly.

Native American Tribes Reach $590 Million Opioid Settlement

All federally recognized tribes in the U.S. will be able to participate in the settlements, even if they did not sue over opioids.

newsy.com

Native American tribes reach a tentative opioid settlement with J&J and distributors

Johnson & Johnson, AmerisourceBergen, McKesson and Cardinal Health will pay $590 million to Native American tribes under a proposed settlement for the companies' role in the opioid crisis.

npr.org

Johnson & Johnson, drug distributors to pay tribes $590 million in opioid deal

Landmark legal settlement offers "measure of justice" to Native American communities hit by opioid epidemic.

cbsnews.com

Native American tribes reach $590 million opioid settlement

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors.

Czechs hit virus record but see significantly fewer deaths

The Czech Republic has recorded a significant decline in people dying of COVID-19 despite facing a record number of infected in one month.

Danes halt virus restrictions; rest of Europe a patchwork

Denmark is scraping most pandemic restrictions as the country no longer considers COVID-19 to be “a socially critical disease.”.

Novavax could offer unvaccinated Americans a new option, if regulators agree

Novavax's shots are based on a kind of "protein subunit" technology that has been used for decades in other routine vaccinations.

cbsnews.com

Novavax could offer unvaccinated Americans a new option, if regulators agree

Novavax's shots are based on a kind of "protein subunit" technology that has been used for decades in other routine vaccinations.

cbsnews.com
Ad

Stocks making the biggest moves in the premarket: 3M, Johnson & Johnson, General Electric and more

The stocks making the biggest moves in premarket trading include 3M, Johnson & Johnson, General Electric and more.

cnbc.com

J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report

Johnson & Johnson on Tuesday projected that its Covid vaccine would generate $3 billion to $3.5 billion in sales in 2022, after posting a mixed fourth-quarter report that slightly beat on earnings' estimates but missed on revenue. Revenue: $24.8 billion, vs. $25.29 billion expectedCFO Joseph Wolk told CNBC a strengthening dollar negatively impacted top line sales by $150 million to $200 million. Hospital staffing shortages caused by the omicron Covid variant also generated uncertainty in the company's medical devices business, particularly with elective procedures, Wolk said. J&J reported $93.77 billion in sales in 2021, a 13.6% increase over the prior year. J&J said it expects to generate $10.40 to $10.60 in earnings per share this year and $98.9 billion to $100.4 billion in revenue.

cnbc.com

Prescription drugs, medical devices boost J&J in Q4

Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the health care giant’s COVID-19 vaccine gained momentum as well.

Ron Johnson says mouthwash can kill COVID-19. Manufacturer of Listerine, medical experts say there's no evidence yet to prove that.

The Wisconsin senator said a "standard gargle" of mouthwash "has been proven to kill the coronavirus" or may reduce viral replication.

news.yahoo.com

Johnson & Johnson is spinning off its consumer division, which could come with risks

Wall Street analysts say Johnson & Johnson's decision to spin off its consumer division is overall a smart business move but it could come with some risks.

cnbc.com

New COVID studies show promise for the Johnson & Johnson vaccine booster

Two studies that have not yet been peer reviewed indicate increased protection against the infectious omicron variant.

npr.org

Marjorie Taylor Greene, who has boasted about being unvaccinated, owns stock in 3 major vaccine makers

Insider's Conflicted Congress project revealed Greene holds AstraZeneca, Pfizer, and Johnson & Johnson stock, each worth between $1,000 and $15,000.

news.yahoo.com

Spurs tickets, H-E-B gift cards being given to those who get vaccines at Travis Park on Wednesday

Metro Health pop-up clinic takes place from 10 a.m. to 5 p.m., Wednesday

P&G shampoo recall is only the latest for benzene in spray products

More than half a dozen recalls have been issued this year as carcinogen is also found in sunscreens, foot deodorants.

cbsnews.com
Ad

Oregon, among last holdout states, to join opioid agreement

Oregon is on the verge of signing onto a $26 billion settlement with the three largest distributors of opioids and drugmaker Johnson & Johnson after being one of the latest holdout states to join.

South Africa's president back to work after COVID isolation

South African President Cyril Ramaphosa has returned to work following a week of isolation after testing positive for COVID-19

washingtonpost.com

Stocks making the biggest moves midday: FedEx, Oracle, Johnson & Johnson and more

These are the stocks posting the largest moves in midday trading.

cnbc.com

Omicron variant reported in 38 states as COVID cases across the country increase

Though reported Omicron cases have so far been mild, experts advise that every precaution should be taken to prevent infection.

cbsnews.com

CDC reports heart inflammation cases among young kids who got Pfizer COVID-19 shot

The U.S. Centers for Disease Control and Prevention said on Thursday it had received reports of eight cases of myocarditis, a type of heart inflammation, in children aged 5-11 years who received Pfizer and BioNTech's COVID-19 vaccine.

news.yahoo.com

CDC expert panel prefers Pfizer, Moderna vaccines over J&J shots for adults due to rare blood clot cases

The Advisory Committee on Immunization Practices voted unanimously to recommend Pfizer and Moderna over the Johnson & Johnson vaccine. Seventeen men developed TTS. A week later, the FDA and the CDC lifted the pause on J&J shots after the independent advisory panel said the benefits of the shots outweighed the risks. In October, the FDA and CDC authorized J&J boosters for all adults at least two months after receiving their initial J&J shot. People who received their primary vaccination with the J&J shot can also get boosted with the Pfizer or Moderna vaccines.

cnbc.com

CDC recommends Pfizer, Moderna COVID-19 shots over J&J's

U.S. health officials say most Americans should get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.

EU regulators: J&J vaccine booster OK to give after 2 months

The European Union drugs regulator said Wednesday that people 18 and older can receive a booster shot for the Johnson & Johnson COVID-19 vaccine at least two months after their initial shot of the one-dose vaccine.

Supreme Court rejects Johnson & Johnson request to halt talcum powder suit

Mississippi alleges the consumer products giant failed to warn users of "potentially lethal" health risks.

cbsnews.com
Ad

High court won't hear Mississippi lawsuit over talcum powder

The Supreme Court has turned away a request by Johnson & Johnson to halt a Mississippi lawsuit over its talcum power products.

Covax promised 2 billion vaccine doses to help the world’s neediest in 2021. It won’t even deliver even half that.

The U.N.-led initiative is now aiming for 800 million doses to be delivered by the end of the year, but that isn't assured.

washingtonpost.com

Ron Johnson says mouthwash can kill COVID-19. Manufacturer of Listerine, medical experts say there's no evidence yet to prove that.

Johnson said a "standard gargle" of mouthwash "has been proven to kill the coronavirus" or may reduce viral replication.

news.yahoo.com

CEOs and scientists on whether existing vaccines will work against Omicron

Moderna president said current COVID-19 vaccines probably aren't effective against the new variant.

cbsnews.com

CEOs and scientists on whether existing vaccines will work against Omicron

Moderna president said current COVID-19 vaccines probably aren't effective against the new variant.

cbsnews.com

CEOs and scientists on whether existing vaccines will work against Omicron

Moderna president said current COVID-19 vaccines probably aren't effective against the new variant.

cbsnews.com

The Winter of Complicated Vaccination Statuses

Some people are unboosted. Others mixed and matched the brands of their shots. Which differences matter?

theatlantic.com

Laredoans debate booster shots becoming part of being ‘fully vaccinated’

The term “fully vaccinated” when it comes to COVID-19 means getting two jabs of...

lmtonline.com

How vaccine makers plan to address the new COVID-19 omicron variant

A new coronavirus variant, first discovered in South Africa, has begun to spread around the globe. Vaccine producers say they're working to get ahead of the new strain.

npr.org
Ad

Pfizer and BioNTech investigating new Covid variant, as J&J tests vaccine against mutated virus

Pfizer and BioNTech said they expect more data from lab tests in two weeks at the latest.

cnbc.com

Canada becomes first country to fully approve Johnson & Johnson's COVID-19 vaccine

The full authorization makes Canada the first country to do so for Johnson & Johnson's COVID vaccine.

cbsnews.com

Your questions about the GE and Johnson & Johnson company breakups, answered

Are you one of the many Americans invested in GE or Johnson & Johnson? Here's what you need to know about their upcoming moves, according to experts.

cnbc.com

Millions of dollars headed to Bexar County to help opioid addicts get more resources

Bexar County residents who have an opioid addiction will soon have more resources available to help them after the county approved a roughly $12 million portion of a settlement between the State of Texas and Johnson & Johnson worth more than $290 million.

Washington seeks over $38 billion from opioid distributors

Washington Attorney General Bob Ferguson has taken the state’s case against the nation’s three biggest drug distributors to trial.

Johnson & Johnson to split into 2, aim for faster growth

Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine from its medical device and prescription drug business.

All Czech students to be tested to curb surge in virus cases

The Czech government is requiring children to get tested for COVID-19 as part of efforts to curtail a recent steep rise in cases.

Oklahoma court overturns $465M opioid ruling against J&J

The Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state’s public nuisance law.

NBA to players, coaches, refs: Booster shots are recommended

The NBA has told its players, coaches and referees that they should receive booster shots against the coronavirus, with particular urgency for those who received the single-dose Johnson & Johnson vaccine.

Ad

Drug companies win in California opioid crisis lawsuit

Top drug manufacturers have won a round in a California lawsuit that blamed them for the opioid crisis and sought billions of dollars to cover the costs of dealing with it.

California judge rules for opioid makers in damages lawsuit

A California judge has ruled for top drug manufacturers as local governments seek billions of dollars to cover their costs from the nation’s opioid epidemic.

Wondering who can get a COVID-19 vaccine booster shot and when? Here’s what Texans need to know.

The vaccine’s protection goes down with time, so medical experts recommend a supplemental dose after two to six months. Find out here if it’s time to get one.

FDA sets stronger safety warnings for breast implants

The Food and Drug Administration is enforcing new warnings on breast implants.

Moderna, Johnson & Johnson booster shots to be provided by Metro Health starting Wednesday

Metro Health will administer COVID-19 booster doses of the Moderna and Johnson & Johnson vaccines beginning Wednesday at its COVID-19 vaccine pop-up clinics.

Asian stocks mixed after Wall Street rises for 5th day

Asian stock markets are higher after Wall Street rose for a fifth day on strong corporate earnings.

J&J hikes 2021 profit forecast, COVID-19 vaccine sales grow

Sales of the cancer treatment Darzalex helped Johnson & Johnson deliver better-than-expected third quarter earnings, while COVID-19 fueled vaccine revenue and had more customers reaching for Tylenol.

Cities, police unions clash as vaccine mandates take effect

Police departments that are requiring officers to be vaccinated against COVID-19 are running up against pockets of resistance across the U.S. Police unions and officers are pushing back by filing lawsuits to block the mandates.

FDA panel endorses booster shot for J&J COVID-19 vaccine

A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

Ad

FDA grapples with timing of booster for J&J COVID-19 vaccine

The Food and Drug Administration is wrestling with how to decide on booster doses of the single-shot Johnson & Johnson COVID-19 vaccine.

The Latest: Manufacturer recalling some at-home test kits

COVID-19 test kit maker Ellume is recalling some at-home tests after learning that they were reporting a higher-than-expected rate of false positive results.

J&J seeks US clearance for COVID-19 vaccine booster doses

Johnson & Johnson has asked U.S. regulators to allow booster shots of its COVID-19 vaccine as the U.S. government moves toward shoring up protection in more vaccinated Americans.

Am I fully vaccinated without a COVID-19 vaccine booster?

People who got a two-dose vaccine or one dose of the Johnson & Johnson shot are considered fully vaccinated — even without a booster.

Slovenia police use water cannons at anti-COVID pass protest

Police in Slovenia have fired tear gas and water cannons at thousands of protesters who are against tough anti-coronavirus measures in the small European nation.

How much Texas gets from multistate, $26 billion opioid settlement hinges on how many local governments sign on

The state and its political subdivisions could get up to $1.5 billion from the settlement. But some local governments are considering pursuing their own lawsuits against drug makers and distributors.

J&J: Booster dose of its COVID shot prompts strong response

Johnson & Johnson says a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose.

WHO, partners aim to get Africa 30% of needed doses by Feb

The World Health Organization and its partners hope to provide Africa with about 30% of the COVID-19 vaccines the continent needs by February.

Companies: $26B settlement of opioid lawsuits to move ahead

Four companies say they'll move ahead with a $26 billion settlement of lawsuits over the opioid crisis.

Ad

Vaccines made in South Africa to stay in Africa, says envoy

Vaccine doses produced by a plant in South Africa will no longer be exported to Europe after the intervention of South Africa’s government, the African Union’s COVID-19 vaccine envoy said Thursday.

J&J: Potential HIV vaccine falls short in mid-stage study

Johnson & Johnson says its potential HIV vaccine did not provide protection against the virus in a study of young women in sub-Saharan Africa.

South Africa gets more vaccines from US amid ongoing surge

South Africa will this weekend receive 2.2 million Pfizer-BioNTech vaccine doses donated by the United States to add to the 5.6 million doses it received from the U.S. in July.

What does full approval of Pfizer’s COVID-19 vaccine mean?

Pfizer’s COVID-19 vaccine has been given the Food and Drug Administration's full approval, meaning it has now undergone the same rigorous regulatory review as dozens of other established vaccines.

J&J CEO Gorsky to step down, company veteran to lead in 2022

Johnson & Johnson will replace Chairman and CEO Alex Gorsky with another veteran company executive starting next year.

Do I need a booster if I got the Johnson & Johnson vaccine?

The U.S. is planning booster doses of the Pfizer and Moderna COVID-19 vaccines, but if you got the one-dose Johnson & Johnson shot instead, stay tuned.

South African activists slam J&J for exporting vaccines

Health activists in Africa have slammed Johnson & Johnson for exporting vaccines produced in South Africa to countries in Europe, which have already immunized a large proportion of their populations and often have a surplus of vaccines.

West African health officials race to vaccinate amid spikes

Thousands of new coronavirus cases have been reported in West Africa in recent weeks amid low vaccination rates and the spread of the delta variant.

To get shots in arms, governments turn to money in pockets

Millions of people in the U.S. who haven’t gotten the COVID-19 vaccine could soon have a new reason to roll up their sleeves: money in their pockets.

States race to use COVID-19 vaccines before they expire

Hundreds of thousands of COVID-19 vaccine doses have been saved from the trash after U.S. regulators extended their expiration date for a second time.

  • Closed Captioning
  • Contests and Rules
  • KSAT Internships
  • Email Newsletters
  • Subscribe to KSAT RSS Feeds
  • Contact Us
  • Careers at KSAT
  • Terms of Use
  • Privacy Policy
  • Public File
  • FCC Applications
  • Do Not Sell My Info
Follow Us
facebook
twitter
instagram
youtube
rss
Get Results with Omne
Omne Results Logo

If you need help with the Public File, call 210-351-1241.


Graham Media Group LogoGraham Digital Logo

Copyright © 2022 KSAT.com is managed by Graham Digital and pubished by Graham Media Group, a division of Graham Holdings.